Nr 601 week 2 copd - Study guides, Class notes & Summaries

NR 601 Week 2 COPD Case Study Part 2, NR 601: Care of the Maturing and Aged Family, Chamberlain

NR 601 Week 2 COPD Case Study Part 1 (Initial post, Faculty and Peer responses), NR 601: Care of the Maturing and Aged Family, Chamberlain

NR 601 Week 2 COPD Case Study Part 1 (Initial post, Faculty and Peer responses) J.D. is a 62 y/o Caucasian male that presents to the office today with the CC of persistent cough for the past 6 months with a recent onset of SOB. Cough is intermittent and frequent and is noted to be worse in the AM. Cough is productive. The sx are aggravated by activity and are relieved by rest. Tx has been Robitussin DM OTC without any relief of sx. Severity of sx; he is unable to walk greater than 20ft w/o sto...

NR 601: WEEK 2: TEST KNOWLEDGE CHECK 2024 NR 601: WEEK 2: TEST KNOWLEDGE CHECK 2024 NR 601 WEEK 2 QUIZ Score for this quiz: 10 out of 10. A >12% change from pre-bronchodilator to post-bronchodilator results indicate which of the following ? the obstruction is not reversible the patient has emphysema the patient has mild COPD the obstruction is reversible An increase in the FEV 1 of > 12% after 2 bronchodilator puffs indicates reversibility. A postbronchodi...

NR 601: WEEK 2: TEST KNOWLEDGE CHECK 2024 NR 601: WEEK 2: TEST KNOWLEDGE CHECK 2024 NR 601 WEEK 2 QUIZ Score for this quiz: 10 out of 10. A >12% change from pre-bronchodilator to post-bronchodilator results indicate which of the following ? the obstruction is not reversible the patient has emphysema the patient has mild COPD the obstruction is reversible An increase in the FEV 1 of > 12% after 2 bronchodilator puffs indicates reversibility. A postbronchodi...

Case Study – Part 2 You ordered a CXR and spirometry at the previous visit and he returns today to review the results. Physical exam and symptoms are … since last visit. Vital signs at this vis it are: Temp-98.3, P-68, RR-20, BP 152/90, Height 68.9in., Weight 258 pounds, O2sat 94% on RA CXR Result: No acute infiltrates or consolidations are seen. Cardiac and mediastinal silhouettes are normal. No hilar enlargement is evident. Osseous thorax is intact. Spirometry Results: … Continue Require...

NR 601: WEEK 2: TEST KNOWLEDGE CHECK 2024 NR 601: WEEK 2: TEST KNOWLEDGE CHECK 2024 NR 601 WEEK 2 QUIZ Score for this quiz: 10 out of 10. A >12% change from pre-bronchodilator to post-bronchodilator results indicate which of the following ? the obstruction is not reversible the patient has emphysema the patient has mild COPD the obstruction is reversible An increase in the FEV 1 of > 12% after 2 bronchodilator puffs indicates reversibility. A postbronchodi...

NR 601 Midterm review 2024 already passed FEV1 Greater than or equal to 80% predicted Gold 1: Mild COPD 50% less than or equal to FEV1 Less than 80% predicted Gold 2: Moderate COPD 30% less than or equal to FEV1 Less than 50% predicted Gold 3: Severe COPD FEV1 Less than 30% predicted Gold 4: Very severe COPD What gold guidelines suggest following meds for COPD Long acting bronchodilators (LABA) A long acting muscarinic antagonist (LAMA) or both Inhaled corticosteroids (ICS) Although not for ...

Nr 601 week 1 pulmonary function test prep aration assignment notes Nr 601 week 1 pulmonary function test prer aration assignment notes pg. 1 NR 601-Week 1 Note PFT interpretation: Step 1 FEV1 normal 80% -120% , FVC 80% -120%, FEV1/FVC ratio >70% Step 2 Gold 1 (mild) EFV1 > or equal 80% predicted Gold 2 (Moderate) EFV1 > 50-79% predicted Gold 3 (severe) EFV1 > 30-49% predicted Gold 4 (very severe) EFV1 < 30 predicted Step 3 Reversibility: Reversibility is measured b...

NR 601 Week 2 COPD Susan Brown Case Study Part 2 Week 2: COPD Case Study: Part 2 NR-601 Primary Care of the Maturing and Aged Family Susan Brown January 2020 Primary diagnosis: 1. Chronic Obstructive Pulmonary Disease (COPD) Pertinent positives to support the diagnosis of COPD include: Spirometry results prebronchodilator FEV1/FV ratio 0.52 and a post-bronchodilator FEV1/FV 0.52. A FEV1/FVC ratio of less than 0.7 constitutes a diagnosis of COPD in symptomatic patients (GOLD, 2019). J....